Company / Book Value per Share
AVADEL PHARMACEUTICALS PLC Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.776
FY2024
5-year range
-$0.352 / $2.953
FY2020-FY2024
Trend
-29.1%
vs FY2023
Sector context
#174 of 209
Health Care
What the data says
AVADEL PHARMACEUTICALS PLC's book value per share of $0.776 is lower than 83% of companies in the Health Care sector (FY2024). Book Value per Share has fluctuated over the past 10 years, ranging from -$0.781 in FY2019 to $2.953 in FY2020.
Based on SEC 10-K filings.
$0.776 in FY2024 with a 3-year CAGR of -16.6%.
Improved from -$0.352 to $0.776 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -16.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.6% below sector average
Key checks
Key Insights
- 3-year CAGR of -16.6%, indicating a declining trend.
- In FY2024, book value per share decreased 29.1% year-over-year.
- Ranks #174 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -28.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.776 | -29.1% |
| FY2023 | $1.094 | +411.0% |
| FY2022 | -$0.352 | -126.3% |
| FY2021 | $1.337 | -54.7% |
| FY2020 | $2.953 | +478.3% |
| FY2019 | -$0.781 | -1148.1% |
| FY2018 | $0.074 | -96.4% |
| FY2017 | $2.049 | +100.9% |
| FY2016 | $1.02 | -35.7% |
| FY2015 | $1.585 | +129.4% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026